Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1Breast 1

Conditions

Hereditary Breast and Ovarian Cancer Syndrome 2Uterine Cervical Neoplasms 1Paraneoplastic Syndromes 1Ovarian Neoplasms 1Dermoid Cyst 1Colorectal Neoplasms, Hereditary Nonpolyposis 1Cervical Adenocarcinoma 1Anti-N-Methyl-D-Aspartate Receptor Encephalitis 1

Interventions

Surveys and Questionnaires 10Colonoscopy 6Specimen Handling 5Observation 4Genetic Testing 4Magnetic Resonance Spectroscopy 3Interviews as Topic 3High-Throughput Nucleotide Sequencing 3Genetic Counseling 3Endoscopy 3Biopsy 3Nivolumab 2Naproxen 2Mesalamine 2Educational Status 2Aspirin 2toripalimab 1tislelizumab 1spartalizumab 1pembrolizumab 1dehydroftorafur 1atezolizumab 1acetylsalicylic acid lysinate 1Telemedicine 1Taxes 1Secretin 1Salpingo-oophorectomy 1RAD51C protein, human 1Physical Examination 1Patient Navigation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Colorectal Neoplasms, Hereditary Nonpolyposis × Salpingo-oophorectomy × Clear all
NCT03294343 2017-12-26

Risk-Reducing Surgeries for Hereditary Ovarian Cancer

Peking Union Medical College Hospital

Phase NA Unknown
600 enrolled
BreastGastrointestinalGynecologic

Colorectal Neoplasms, Hereditary Nonpolyposis, Hereditary Breast and Ovarian Cancer Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡